Page last updated: 2024-08-24

naphthalimides and Adverse Drug Event

naphthalimides has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borad, MJ; Chalasani, P; Kurtin, S; Mahadevan, D; Northfelt, DW; Rensvold, D; Tibes, R; Von Hoff, DD	1

Trials

1 trial(s) available for naphthalimides and Adverse Drug Event

Article	Year
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma. International journal of clinical oncology, 2013, Volume: 18, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Animals; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Mice; Middle Aged; Naphthalimides; Neoplasm Metastasis; Neoplasm Staging; Rats; Urea	2013

Article

Year

Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma.

International journal of clinical oncology, 2013, Volume: 18, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Animals; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Mice; Middle Aged; Naphthalimides; Neoplasm Metastasis; Neoplasm Staging; Rats; Urea

2013